|
Market Closed -
Other stock markets
|
Pre-market 09:30:22 | |||
| 166.00 EUR | -1.43% |
|
169.05 | +1.84% |
| 09:39am | Ipsen's Migraine Treatment Meets Primary Endpoints in Late-stage Trial | MT |
| 07-07 | AlphaValue/Baader Europe Cuts Ipsen Price Target Amid Future Patent Expiries, Mid-term Risks | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 161.33 | -2.81% | 15 | ||||||
| 1,240.46 | +2.03% | 28 | ||||||
| 258.59 | -1.83% | 22 | ||||||
| 258.32 | +2.21% | 28 | ||||||
| 359.22 | +7.26% | 18 | ||||||
| 217.01 | +14.04% | 22 | ||||||
| 153.92 | -1% | 21 | ||||||
| 316.91 | -1.93% | 24 | ||||||
| 354.97 | -3.54% | 29 | ||||||
| 158.3 | +16.55% | 27 | ||||||
| 28.93 | +20.28% | 27 | ||||||
| 554.28 | +11.21% | 25 | ||||||
| 63 | +9.49% | 24 | ||||||
| 21.14 | +6.81% | 19 | ||||||
| 96.31 | +27.79% | 23 | ||||||
| 10,006.67 | +36.24% | 15 | ||||||
| 53.69 | +8.17% | 18 | ||||||
| 81.21 | +50.37% | 15 | ||||||
| 6,106.87 | +12.03% | 15 | ||||||
| 4.142 | +13.96% | 17 | ||||||
| Average | 1,024.76 | +11.37% | 22 | ||||||
| Weighted average by Cap. | 701.6 | +5.68% | 24 |
- Stock Market
- Stocks
- IPN Stock
- Sector Ipsen
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
